SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease

Eur J Gastroenterol Hepatol. 2022 Aug 1;34(8):883-884. doi: 10.1097/MEG.0000000000002379. Epub 2022 Jun 29.

Antonio Tursi^{1

2}, Loris Riccardo Lopetuso^{3

4

5}, Lorenzo Maria Vetrone⁵, Antonio Gasbarrini^{5

6}, Alfredo Papa^{5

6}

¹ Territorial Gastroenterology Service, ASL BAT, Andria.
² Department of Medicine and Surgery, Post-Graduate School of Digestive Disease, Catholic University, Rome.
³ Department of Medicine and Ageing Sciences, "G. d'Annunzio" University of Chieti- Pescara.
⁴ Center for Advanced Studies and Technology (CAST), "G. d'Annunzio" University of Chieti-Pescara, Chieti.
⁵ CEMAD, Digestive Disease Center, Fondazione Policlinico A. Gemelli, IRCCS.
⁶ Department of Medicine and Surgery, Catholic University, Rome, Italy.

No abstract available

Publication types